Lv1
50 积分 2026-01-16 加入
A Phase 1, Randomised, Double‐Blind, Placebo‐Controlled Trial Investigating the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of KN069 (a Dual GLP ‐ 1R Agonist and GIPR Antagonist) in Male Adults With Overweight or Obesity
1个月前
已完结
Factor XI Inhibitors: Potential Role in End-Stage Kidney Disease
3个月前
已完结
Laboratory Monitoring of Heparin Anticoagulation in Hemodialysis: Rationale and Strategies
3个月前
已完结
Subcutaneous Administration of Therapeutic Monoclonal Antibody Drug Products Using a Syringe in Blinded Clinical Trials: Advances and Key Aspects Related to Blinding/Matching/Masking Strategies for Placebo Formulation
4个月前
已完结
Methods Article for a Study Protocol: Study Design and Baseline Characteristics of the Treatment of Cardiovascular Disease with Low Dose Rivaroxaban in Advanced Chronic Kidney Disease (TRACK) Trial
4个月前
已完结
SGLT2 inhibitors: not for hypertension but exceedingly useful in hypertension
5个月前
已关闭
Comparative efficacy of glucose‐lowering medications on body weight and blood pressure in patients with type 2 diabetes: A systematic review and network meta‐analysis
5个月前
已完结
Prevalence of Chronic Kidney Disease in China
6个月前
已完结
皖公网安备34019202002308
